CorMedix CRMD Income Statement (2010-2026)

NASDAQ CRMD
$5.37 -0.10 (-1.83%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

CorMedix Quarterly Income Statement

Periods 61 quarters
Latest Jun 2026

CorMedix reported revenue of $101.93M for the quarter ended Jun 2026, up 156.5% year over year. This income statement covers 61 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Dec2013 Mar2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
0.04M0.06M0.01M0.02M0.01M0.03M0.81M11.46M31.21M39.08M39.74M104.28M128.62M101.93M
Cost of RevenueCost of Rev
0.03M0.05M0.00M332.000.00M406.000.82M0.51M0.63M1.12M1.60M1.81M7.57M11.17M14.51M
Gross Profit
0.01M0.01M0.01M0.02M0.01M0.03M-0.82M0.30M10.77M30.03M37.48M37.87M93.08M107.31M77.13M
Operating items
Amortization - Intangibles
0.05M0.05M0.05M3.63M10.14M10.30M
Research & DevelopmentR&D
4.74M3.24M2.29M3.21M2.34M2.84M3.41M4.79M2.66M2.29M0.84M0.65M0.73M1.73M3.19M2.44M5.10M8.60M6.68M
Selling, General & AdministrativeSG&A
3.84M4.55M4.75M5.05M4.63M5.58M7.61M3.75M3.74M5.22M8.71M7.56M6.58M7.11M9.69M9.50M25.45M23.57M15.09M
Other Operating ExpensesOther Opex
0.80M0.71M3.26M4.06M8.16M6.34M7.39M6.75M8.26M4.47M0.81M-2.40M-4.10M-6.72M
Operating ExpensesOpex
8.58M7.79M7.04M8.26M6.97M8.42M11.02M11.80M10.47M15.67M15.89M15.60M14.06M17.10M17.36M18.33M41.73M48.18M34.22M
Operating IncomeOp. Inc
-8.56M-7.78M-7.03M-8.24M-6.96M-8.39M-11.02M-11.80M-10.47M-15.67M-16.70M-15.30M-3.29M12.94M20.13M19.54M51.35M59.13M42.91M
Non-operating items
Non Operating Interest Expenses
0.01M0.01M0.01M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.95M1.82M
Gains (Losses) on Sale of Assets & InvestmentsGains on Sales
3.09M2.27M2.55M
Interest & Investment IncomeInt & Inv Inc
0.00M0.00M0.01M0.04M0.09M0.18M0.45M0.55M0.77M0.92M0.86M0.66M0.55M0.51M0.57M0.83M1.56M0.89M
Other Non Operating IncomeOther Non Op Inc.
0.00M-0.01M-0.01M0.05M0.11M0.18M0.45M0.53M-0.03M0.00M0.00M0.50M-0.03M0.03M-0.04M-0.02M-0.07M0.08M
Non Operating IncomeNon Op. Inc.
0.72M0.91M0.84M1.15M0.51M0.53M0.52M0.81M1.23M-2.68M-4.18M
Net income details
EBIT
-8.56M-7.78M-7.03M-8.24M-6.96M-8.39M-11.02M-11.80M-10.47M-15.67M-16.70M-15.30M-3.29M12.94M20.13M19.54M51.35M59.13M42.91M
EBT
-8.57M-7.79M-7.02M-8.19M-6.85M-8.21M-10.57M-11.27M-9.74M-14.75M-15.86M-14.15M-2.78M13.46M20.64M20.35M52.58M56.45M38.73M
Tax ProvisionsTaxes
-0.59M-1.39M-0.01M0.01M-230.000.52M-55.99M42.43M12.75M
Income After Tax
-8.57M-7.79M-7.02M-7.60M-6.85M-8.21M-10.57M-11.27M-9.74M-14.75M-14.47M-14.15M-2.78M13.46M20.64M19.83M108.56M14.02M25.99M
Income from Continuing OperationsIncome (Continuing)
-8.57M-7.79M-7.02M-7.60M-6.85M-8.21M-10.57M-11.27M-9.74M-14.75M-14.47M-14.15M-2.78M13.46M20.64M2.03M108.56M6.20M
Consolidated Net IncomeConsol Net Inc.
-8.57M-7.79M-7.02M-7.60M-6.85M-8.21M-10.57M-11.27M-9.74M-14.75M-14.47M-14.15M-2.78M13.46M20.64M2.03M108.56M6.20M
Income towards Parent CompanyParent Net Inc
-8.57M-7.79M-7.03M-7.60M-6.85M-8.21M-10.57M-11.27M-9.74M-14.75M-14.47M-14.15M-2.78M13.46M20.64M19.83M108.56M12.36M25.99M
Preferred Dividend PaymentsPref Dividends
Net Income towards Common StockholdersNet Income
8.60M-7.79M7.00M7.60M-6.85M-8.21M-10.57M-11.27M-9.74M-14.75M-14.47M-14.15M-2.78M13.46M20.64M19.83M108.56M12.36M25.99M
Additional items
EPS (Basic)
0.23-0.210.180.19-0.17-0.20-0.24-0.25-0.17-0.29-0.25-0.25-0.050.230.320.291.430.160.33
EPS (Diluted)
0.23-0.210.180.19-0.17-0.20-0.24-0.25-0.17-0.29-0.25-0.25-0.050.230.300.281.260.150.28
Shares Outstanding
38.11M37.67M38.25M39.76M41.18M40.27M44.09M45.37M56.55M50.90M57.50M57.62M58.83M58.87M65.24M67.93M75.93M75.93M78.44M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
38.11M37.67M38.25M39.76M41.18M40.27M44.09M45.37M56.55M50.90M57.50M57.62M58.83M58.87M68.98M71.92M86.21M80.31M92.48M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
38.09M38.09M38.73M41.11M41.21M42.82M44.50M45.81M54.81M54.94M54.96M55.27M57.89M64.41M67.71M74.62M78.35M77.67M
EBITDA
-8.55M-7.76M-7.01M-8.22M-6.94M-8.37M-11.00M-11.79M-10.45M-15.65M-16.68M-15.28M-3.21M13.11M20.29M19.71M55.11M69.59M74.20M53.45M
Interest ExpensesInt Expense
0.01M0.01M0.01M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.95M1.82M
Tax Rate
2.57%75.16%32.90%

CorMedix Income Statement API

Pull CorMedix's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CRMD&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY